17-47347921-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_152347.5(EFCAB13):​c.631C>T​(p.Arg211*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.06 in 1,529,114 control chromosomes in the GnomAD database, including 3,898 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.052 ( 389 hom., cov: 30)
Exomes 𝑓: 0.061 ( 3509 hom. )

Consequence

EFCAB13
NM_152347.5 stop_gained

Scores

1
3
3

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.06
Variant links:
Genes affected
EFCAB13 (HGNC:26864): (EF-hand calcium binding domain 13)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 17-47347921-C-T is Benign according to our data. Variant chr17-47347921-C-T is described in ClinVar as [Benign]. Clinvar id is 3059359.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFCAB13NM_152347.5 linkc.631C>T p.Arg211* stop_gained Exon 9 of 25 ENST00000331493.7 NP_689560.3 Q8IY85-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFCAB13ENST00000331493.7 linkc.631C>T p.Arg211* stop_gained Exon 9 of 25 1 NM_152347.5 ENSP00000332111.2 Q8IY85-1
EFCAB13ENST00000517484.5 linkc.517+2823C>T intron_variant Intron 8 of 21 2 ENSP00000430048.1 Q8IY85-2
EFCAB13ENST00000517310.5 linkc.73+2823C>T intron_variant Intron 9 of 10 2 ENSP00000466136.1 K7ELL9
EFCAB13ENST00000520776.5 linkn.651+2823C>T intron_variant Intron 6 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.0520
AC:
7896
AN:
151978
Hom.:
389
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0110
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0361
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.227
Gnomad SAS
AF:
0.123
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0524
Gnomad OTH
AF:
0.0569
GnomAD2 exomes
AF:
0.0737
AC:
17721
AN:
240478
AF XY:
0.0763
show subpopulations
Gnomad AFR exome
AF:
0.00901
Gnomad AMR exome
AF:
0.0227
Gnomad ASJ exome
AF:
0.0392
Gnomad EAS exome
AF:
0.241
Gnomad FIN exome
AF:
0.113
Gnomad NFE exome
AF:
0.0564
Gnomad OTH exome
AF:
0.0677
GnomAD4 exome
AF:
0.0609
AC:
83832
AN:
1377018
Hom.:
3509
Cov.:
31
AF XY:
0.0623
AC XY:
42140
AN XY:
676276
show subpopulations
Gnomad4 AFR exome
AF:
0.00934
AC:
302
AN:
32332
Gnomad4 AMR exome
AF:
0.0245
AC:
1022
AN:
41650
Gnomad4 ASJ exome
AF:
0.0398
AC:
974
AN:
24484
Gnomad4 EAS exome
AF:
0.222
AC:
8467
AN:
38136
Gnomad4 SAS exome
AF:
0.113
AC:
7979
AN:
70678
Gnomad4 FIN exome
AF:
0.110
AC:
5596
AN:
50924
Gnomad4 NFE exome
AF:
0.0522
AC:
55207
AN:
1056970
Gnomad4 Remaining exome
AF:
0.0699
AC:
3943
AN:
56382
Heterozygous variant carriers
0
3478
6956
10434
13912
17390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2272
4544
6816
9088
11360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0518
AC:
7884
AN:
152096
Hom.:
389
Cov.:
30
AF XY:
0.0558
AC XY:
4146
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.0109
AC:
0.0109413
AN:
0.0109413
Gnomad4 AMR
AF:
0.0361
AC:
0.0360697
AN:
0.0360697
Gnomad4 ASJ
AF:
0.0363
AC:
0.0363322
AN:
0.0363322
Gnomad4 EAS
AF:
0.228
AC:
0.227623
AN:
0.227623
Gnomad4 SAS
AF:
0.122
AC:
0.122195
AN:
0.122195
Gnomad4 FIN
AF:
0.121
AC:
0.120644
AN:
0.120644
Gnomad4 NFE
AF:
0.0524
AC:
0.0524388
AN:
0.0524388
Gnomad4 OTH
AF:
0.0568
AC:
0.0568182
AN:
0.0568182
Heterozygous variant carriers
0
353
706
1060
1413
1766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0557
Hom.:
617
Bravo
AF:
0.0436
TwinsUK
AF:
0.0475
AC:
176
ALSPAC
AF:
0.0462
AC:
178
ESP6500AA
AF:
0.0134
AC:
59
ESP6500EA
AF:
0.0533
AC:
458
ExAC
AF:
0.0734
AC:
8913
Asia WGS
AF:
0.188
AC:
651
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

EFCAB13-related disorder Benign:1
Feb 19, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.042
T
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
37
DANN
Uncertain
1.0
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Benign
0.26
N
Vest4
0.075
GERP RS
2.4
Mutation Taster
=174/26
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.56
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.56
Position offset: 30

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs71377306; hg19: chr17-45425287; COSMIC: COSV58946778; COSMIC: COSV58946778; API